ARBUTUS BIOPHARMA CORP's ticker is ABUS and the CUSIP is 03879J100. A total of 110 filers reported holding ARBUTUS BIOPHARMA CORP in Q2 2022. The put-call ratio across all filers is 0.82 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $81,281 | -19.7% | 40,040 | -9.0% | 0.05% | -18.3% |
Q2 2023 | $101,255 | -10.2% | 44,024 | +18.4% | 0.06% | -3.2% |
Q1 2023 | $112,707 | -6.1% | 37,197 | -27.8% | 0.06% | -1.6% |
Q4 2022 | $119,986 | +46.3% | 51,496 | +19.8% | 0.06% | +90.9% |
Q3 2022 | $82,000 | -29.3% | 42,988 | +0.7% | 0.03% | -23.3% |
Q2 2022 | $116,000 | +3.6% | 42,675 | +14.0% | 0.04% | -14.0% |
Q1 2022 | $112,000 | -27.3% | 37,448 | -5.6% | 0.05% | -13.8% |
Q4 2021 | $154,000 | -31.6% | 39,675 | -27.2% | 0.06% | -81.3% |
Q1 2016 | $225,000 | – | 54,471 | – | 0.31% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Whitefort Capital Management, LP | 11,895,477 | $24,147,818 | 12.66% |
Two Seas Capital LP | 8,280,818 | $16,810,061 | 3.38% |
FourWorld Capital Management LLC | 1,341,907 | $2,724,071 | 0.51% |
Tejara Capital Ltd | 180,077 | $365,556 | 0.21% |
Woodline Partners LP | 4,719,903 | $9,581,403 | 0.11% |
Hudson Bay Capital Management LP | 8,299,808 | $16,848,610 | 0.07% |
Kepos Capital LP | 155,691 | $316 | 0.06% |
Virtus ETF Advisers LLC | 40,040 | $81,281 | 0.05% |
Centiva Capital, LP | 1,071,705 | $2,175,561 | 0.05% |
Kades & Cheifetz LLC | 20,000 | $40,600 | 0.03% |